We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
+15.35%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$370M
AUM Growth
+$95.8M
Cap. Flow
+$73.9M
Cap. Flow %
19.94%
Top 10 Hldgs %
36.28%
Holding
91
New
23
Increased
27
Reduced
13
Closed
22

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$24.7M
2
CVS icon
CVS Health
CVS
+$13.7M
3
GSK icon
GSK
GSK
+$10.5M
4
GILD icon
Gilead Sciences
GILD
+$9.94M
5
GMED icon
Globus Medical
GMED
+$9.18M

Top Sells

Rank Stock Value
1
COR icon
Cencora
COR
+$9.96M
2
CI icon
Cigna
CI
+$9.92M
3
CAH icon
Cardinal Health
CAH
+$9.32M
4
CELG
Celgene Corp
CELG
+$6.56M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$6.31M

Sector Composition

Rank Sector Weight
1 Healthcare 80.51%
2 Industrials 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICPT
51
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2.44M 0.66%
+21,800
New +$2.38M
GNFT
52
DELISTED
Genfit
GNFT
$2.22M 0.6%
+92,637
New +$2.14M
UROV
53
DELISTED
Urovant Sciences Ltd.
UROV
$2.16M 0.58%
215,042
-592,818
-73% -$6.08M
FRTX
54
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$1.94M 0.52%
5,130
– –
LOGC
55
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$1.57M 0.42%
158,958
– –
INGN icon
56
Inogen
INGN
$175M
$1.45M 0.39%
15,189
+2,365
+18% +$295K
ACHV icon
57
Achieve Life Sciences
ACHV
$659M
$1.36M 0.37%
21,074
-8,795
-29% -$355K
SENS icon
58
Senseonics Holdings Inc
SENS
$263M
$1.36M 0.37%
27,743
+3,750
+16% +$199K
IDXG
59
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$1.32M 0.36%
+165,310
New +$1.55M
PFNX
60
DELISTED
Pfenex Inc.
PFNX
$1.32M 0.36%
213,608
– –
RVLP
61
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$1.25M 0.34%
346,410
– –
AFMD
62
DELISTED
Affimed
AFMD
$1.13M 0.3%
26,794
+10,630
+66% +$382K
HRC
63
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$1.02M 0.28%
9,682
-15,000
-61% -$1.51M
AXSM icon
64
Axsome Therapeutics
AXSM
$11.2B
$603K 0.16%
42,410
-338,402
-89% -$3.14M
VTAK icon
65
Catheter Precision
VTAK
$906K
$590K 0.16%
1
-1
-50% -$1.67M
MASI
66
PUT
DELISTED
Masimo
MASI
$456K 0.12%
+3,300
New +$414K
BPMC
67
DELISTED
Blueprint Medicines
BPMC
$240K 0.06%
+3,000
New +$222K
ATNM icon
68
Actinium Pharmaceuticals
ATNM
$26.3M
$163K 0.04%
11,327
– –
LXRX icon
69
PUT
Lexicon Pharmaceuticals
LXRX
$1.03B
$120K 0.03%
21,600
– –
ABT icon
70
Abbott
ABT
$183B
– –
-48,737
Closed -$3.52M
ALGN icon
71
Align Technology
ALGN
$12.1B
– –
-17,847
Closed -$3.74M
AMGN icon
72
Amgen
AMGN
$208B
– –
-17,000
Closed -$3.31M
AMGN icon
73
PUT
Amgen
AMGN
$208B
– –
-50,000
Closed -$9.73M
BDX icon
74
Becton Dickinson
BDX
$45.6B
– –
-16,400
Closed -$3.6M
BMY icon
75
Bristol-Myers Squibb
BMY
$133B
– –
-50,000
Closed -$2.6M
1 2
3
4

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Sio Capital Management held 91 positions worth $370M, up 35% from $275M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Sio Capital Management deployed $73.9M of net new capital in Q1 2019, opening 23 new positions and adding to 27 existing holdings. Its largest new stake was Biogen: 78,596 shares worth $18.6M.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, down from 91% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $6.31M trimmed.

  • Sio Capital Management's largest Q1 2019 buy was Biogen: 78,596 shares worth $18.6M.
  • Sio Capital Management added most to CVS Health in Q1 2019, an estimated $13.7M increase.
  • Sio Capital Management's biggest Q1 2019 reduction was Alnylam Pharmaceuticals, cutting an estimated $6.31M.
  • Sio Capital Management fully exited Cencora in Q1 2019, selling an estimated $9.96M.
  • Sio Capital Management's ten largest holdings make up 36% of its $370M portfolio in Q1 2019.
  • Sio Capital Management opened 23 new positions and closed 22 in Q1 2019.
  • Sio Capital Management's portfolio value rose 35% quarter-over-quarter to $370M.

Based on Sio Capital Management's 13F filing for Q1 2019, filed 15 May 2019.